Tag: biosimilars
Future of Global Generic Markets: Key Trends and Predictions
- By : Tamsin Riverton
- Date : Aug 30 2026
Explore the future of global generic markets with insights on biosimilars, pharmerging growth, and supply chain trends. Discover predictions for 2030.
Generics vs Brand Biologics: Cost Difference Comparison for 2026
- By : Tamsin Riverton
- Date : Aug 21 2026
Discover the real cost difference between brand biologics and biosimilars. Learn how much you can save, why prices vary, and practical tips for navigating your prescription costs in 2026.
How Generic Drugs Control Healthcare Costs: The Economics of Savings
- By : Tamsin Riverton
- Date : Jun 19 2026
Discover how generic drugs reduce healthcare spending by 80-85%. Learn about biosimilars, FDA regulations, and the economic impact of generic competition on patient costs.
How Generic Drugs Control Healthcare Costs: A 2026 Guide
- By : Tamsin Riverton
- Date : Jun 19 2026
Discover how generic drugs cut healthcare costs by 80-85% and dominate 90% of prescriptions. Learn about biosimilars, patent barriers, and real-world savings in this 2026 guide.
Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now
- By : Tamsin Riverton
- Date : Feb 2 2026
Patent expiry means cheaper drugs-but only if you plan ahead. Learn what patients and healthcare systems must do now to avoid disruptions and save money when brand-name medications lose exclusivity.
The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
- By : Tamsin Riverton
- Date : Dec 24 2025
The FDA's Purple Book is the official database for biosimilars and interchangeable biological products. Learn how it works, which products are substitutable, and why state laws still control pharmacy substitutions.
